Position in BIIB
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$961,314,677
+$165,185,454 QoQ
Shares Held
4,449,295
+2.5% QoQ
Ownership
3.01%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#7
of 1,036 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $76,028,444,777 across 14 Drug Manufacturers - General names. BIIB ranks #9 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
20,310,858 | $24,361,454,441 | |
| 2 | JNJ |
Johnson & Johnson
|
59,086,417 | $15,006,177,324 | |
| 3 | ABBV |
AbbVie Inc.
|
46,998,433 | $11,826,685,679 | |
| 4 | MRK |
Merck & Co., Inc.
|
60,744,214 | $7,805,631,499 | |
| 5 | AMGN |
Amgen Inc
|
15,696,068 | $5,683,860,144 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
30,065,642 | $3,798,493,209 | |
| 7 | PFE |
Pfizer Inc
|
135,275,782 | $3,257,440,829 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
56,443,077 | $3,252,250,096 |
All Filings in BIIB
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $961,314,677 | 4,449,295 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $796,129,223 | 4,342,602 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $739,052,229 | 4,199,399 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $569,954,842 | 4,068,781 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $492,080,457 | 3,918,150 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $526,404,868 | 3,846,864 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $565,112,188 | 3,695,476 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $700,347,796 | 3,613,020 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $826,662,005 | 3,565,965 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $735,228,004 | 3,409,674 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $856,351,960 | 3,309,317 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $831,912,327 | 3,236,887 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $906,870,963 | 3,183,679 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $862,653,412 | 3,102,735 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $925,558,023 | 3,342,330 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $880,959,825 | 3,299,475 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $661,891,960 | 3,245,523 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $591,083,438 | 2,806,664 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $658,659,813 | 2,745,331 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $785,372,525 | 2,775,266 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $1,002,018,812 | 2,893,750 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $782,323,952 | 2,796,511 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $675,690,679 | 2,759,498 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $819,828,958 | 2,889,978 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $813,193,074 | 3,039,406 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $1,066,926,375 | 3,372,294 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||